EPS inhibitor treatment of Salmonella impacts evolution without selecting for resistance to biofilm inhibition
Abstract Virulence factors of pathogens, such as toxin production and biofilm formation, often exhibit a public character, providing benefits to nearby non-producers. Consequently, anti-virulence drugs targeting these public traits may not select for resistance, as resistant mutants that resume prod...
| Published in: | npj Biofilms and Microbiomes |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Online Access: | https://doi.org/10.1038/s41522-025-00693-y |
